Sox-2 positive cells identified in lymph nodes from endometriosis patients may play a role in the disease pathogenesis

Eur J Obstet Gynecol Reprod Biol. 2023 Sep:288:124-129. doi: 10.1016/j.ejogrb.2023.07.017. Epub 2023 Jul 25.

Abstract

Objective: This study aimed to characterize Sox-2 in sentinel lymph nodes and randomly obtained lymph nodes from endometriosis (EM) patients for the first time.

Study design: This prospective study analyzed tissue samples from surgical specimens collected from May until December 2007 in the Endometriosis Center Charité, Berlin. Lymph node samples from 38 women aged between 22 and 49 years who underwent laparoscopy due to symptomatic EM were analyzed. The material was obtained either randomly or, in the case of deep infiltrating endometriosis, detected using 4 cc Patent Blue®, labeled intraoperatively, which made the sentinel lymph nodes available for histological examination. Together with hematoxylin and eosin staining, the sections were evaluated by immunohistochemistry with antibodies against estrogen and progesterone receptors and Sox-2. Using double-immunofluorescence microscopy, the colocalization of Sox-2 and estrogen receptors were evaluated.

Results: Sox-2-positive cells were identified in the lymph nodes' cortical and medullary zones, with a higher expression in the medullary layer. Occasionally, Sox-2 positive stained cell groups, called cell nests, could also be detected. The number of Sox-2 positive cells in the sentinel lymph nodes was almost three times higher than in the random lymph nodes (p = 0.031). A significant five-fold increase (p = 0.0013) in Sox-2 expression was seen in the estrogen and progesterone receptor (ER/PR) positive patient group compared to the progesterone receptor positive group or hormone receptor negative patients. Identical hormone-related Sox-2 expression was also detected separately for the sentinel lymph node group (p = 0.0174). Sox-2 showed pronounced colocalisation with estrogen receptors.

Conclusion: The lymphatic involvement in EM is evidence of a systemic disease manifestation and provides evidence of an immune system failure. In recent years, many theories have been studied, but there is no single theory that could explain all aspects of EM. The future concept of EM is likely to incorporate the elements from all the pathogenetic theories already described. Through this study, stem cells and lymphatic metastasis theories were incorporated.

Keywords: Estrogen receptor; Lymphovascular metastasis; Stem cell marker; Transcription factor.

MeSH terms

  • Adult
  • Endometriosis* / pathology
  • Estrogens / metabolism
  • Female
  • Humans
  • Lymph Nodes / pathology
  • Middle Aged
  • Prospective Studies
  • Receptors, Estrogen / metabolism
  • Receptors, Progesterone / metabolism
  • Sentinel Lymph Node Biopsy*
  • Young Adult

Substances

  • Estrogens
  • Receptors, Estrogen
  • Receptors, Progesterone
  • SOX2 protein, human